Luz María González1, Angustias García-Herráiz2, Sonia Mota-Zamorano1, Isalud Flores2, David Albuquerque3,4, Guillermo Gervasini5. 1. Department of Medical and Surgical Therapeutics, Medical School, University of Extremadura, Avda. de Elvas s/n, 06006, Badajoz, Spain. 2. Eating Disorders Unit, Institute of Mental Disorders, Health Service of Extremadura, Badajoz, Spain. 3. Genomics Group, Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain. 4. Department of Life Sciences, Research Center for Anthropology and Health (CIAS), University of Coimbra, Coimbra, Portugal. 5. Department of Medical and Surgical Therapeutics, Medical School, University of Extremadura, Avda. de Elvas s/n, 06006, Badajoz, Spain. ggervasi@unex.es.
Abstract
PURPOSE: The endocannabinoid system plays a key role in eating behavior regulating appetite and reward mechanisms, but the impact of its genetic variability has been scarcely studied in Anorexia Nervosa (AN). We aimed to analyze the association of genetic variants in cannabinoid receptors with the risk for AN and with psychiatric comorbidities that are commonplace in these patients. METHODS: We screened 221 AN patients and 396 controls for 14 tag-SNPs in the CNR1 and CNR2 genes, coding for cannabinoids receptors CB1 and CB2, respectively. Patients were diagnosed according to DSM-5 criteria and interviewed with the SCL-90R and the EDI-2 inventories to identify AN-coupled and general psychopathology. RESULTS: None of the tag-SNPs was significantly related to AN risk. However, the rs806369-TT genotype and haplotype rs806368/rs1049353/rs806369 of CNR1 were respectively associated with lower weight (mean difference = - 4.92 kg, FDR-q = 0.044) and BMI (FDR-q = 0.042) in AN patients. CNR1 rs806374-TT and CNR2 rs3003335-AA and rs6658703-GG genotypes correlated with higher scores in the Positive Symptom Distress Index (PSDI, FDR-q = 0.011 and 0.009, respectively). These three genotypes were also linked to increased Hostility in the patients (FDR-q < 0.05). Remarkably, a proximal area of the CNR1 gene locus (positions 88,143,916-88,149,832) correlated with PSDI, Hostility, Asceticism and EDI-2 total scores after correcting by multiple testing (FDR-q < 0.05 in all instances). Finally, significant CNR1/CNR2 epistasis was observed in relation to Hostility (p < 0.01) and Maturity Fears (p < 0.001). CONCLUSION: The CNR1 and CNR2 genes, coding for cannabinoid receptors, may constitute important loci regarding psychiatric comorbidities in AN patients. LEVEL III: Evidence obtained from well-designed cohort or case-control analytic studies.
PURPOSE: The endocannabinoid system plays a key role in eating behavior regulating appetite and reward mechanisms, but the impact of its genetic variability has been scarcely studied in Anorexia Nervosa (AN). We aimed to analyze the association of genetic variants in cannabinoid receptors with the risk for AN and with psychiatric comorbidities that are commonplace in these patients. METHODS: We screened 221 AN patients and 396 controls for 14 tag-SNPs in the CNR1 and CNR2 genes, coding for cannabinoids receptors CB1 and CB2, respectively. Patients were diagnosed according to DSM-5 criteria and interviewed with the SCL-90R and the EDI-2 inventories to identify AN-coupled and general psychopathology. RESULTS: None of the tag-SNPs was significantly related to AN risk. However, the rs806369-TT genotype and haplotype rs806368/rs1049353/rs806369 of CNR1 were respectively associated with lower weight (mean difference = - 4.92 kg, FDR-q = 0.044) and BMI (FDR-q = 0.042) in AN patients. CNR1 rs806374-TT and CNR2 rs3003335-AA and rs6658703-GG genotypes correlated with higher scores in the Positive Symptom Distress Index (PSDI, FDR-q = 0.011 and 0.009, respectively). These three genotypes were also linked to increased Hostility in the patients (FDR-q < 0.05). Remarkably, a proximal area of the CNR1 gene locus (positions 88,143,916-88,149,832) correlated with PSDI, Hostility, Asceticism and EDI-2 total scores after correcting by multiple testing (FDR-q < 0.05 in all instances). Finally, significant CNR1/CNR2 epistasis was observed in relation to Hostility (p < 0.01) and Maturity Fears (p < 0.001). CONCLUSION: The CNR1 and CNR2 genes, coding for cannabinoid receptors, may constitute important loci regarding psychiatric comorbidities in AN patients. LEVEL III: Evidence obtained from well-designed cohort or case-control analytic studies.
Authors: Filip Rybakowski; Monika Dmitrzak-Weglarz; Aleksandra Szczepankiewicz; Maria Skibinska; Agnieszka Slopien; Andrzej Rajewski; Joanna Hauser Journal: Neuro Endocrinol Lett Date: 2007-04 Impact factor: 0.765
Authors: Vesna Boraska; Oliver S P Davis; Lynn F Cherkas; Sietske G Helder; Juliette Harris; Isabel Krug; Thomas Pei-Chi Liao; Janet Treasure; Ioanna Ntalla; Leila Karhunen; Anna Keski-Rahkonen; Danai Christakopoulou; Anu Raevuori; So-Youn Shin; George V Dedoussis; Jaakko Kaprio; Nicole Soranzo; Tim D Spector; David A Collier; Eleftheria Zeggini Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2012-08-22 Impact factor: 3.568
Authors: Daniela Navarro; Ani Gasparyan; Francisco Navarrete; Abraham B Torregrosa; Gabriel Rubio; Marta Marín-Mayor; Gabriela B Acosta; Maria Salud Garcia-Gutiérrez; Jorge Manzanares Journal: Int J Mol Sci Date: 2022-04-26 Impact factor: 6.208